drugset / Trial / NCT03230162
Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
RandomizedParallel-groupSingle-blindTreatment
Summary
comparing the effect of using sildenafil citrate and LMWH in treatment of cases of IUGR due to placental insufficiency
Timeline
- Start
- 2017-06-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 25 mg | Oral |
| Subject | Tinzaparin | Other / unclassified | 75 iu/kg | Subcutaneous |
| Subject | Tinzaparin | Other / unclassified | 3500 iu | Subcutaneous |
| Subject | Tinzaparin | Other / unclassified | 4500 iu | Subcutaneous |
| Subject | Tinzaparin | Other / unclassified | 7000 iu | Subcutaneous |
| Subject | Tinzaparin | Other / unclassified | 9000 iu | Subcutaneous |